Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group (Q28141764)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: 16 September 2000)
edit
Language Label Description Also known as
English
Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group
scientific article (publication date: 16 September 2000)

    Statements

    Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group (English)
    0 references
    0 references
    P A Quint
    0 references
    B Goldstein
    0 references
    P Barton
    0 references
    J S Bradley
    0 references
    S D Shemie
    0 references
    T Yeh
    0 references
    S S Kim
    0 references
    D P Cafaro
    0 references
    P J Scannon
    0 references
    B P Giroir
    0 references
    16 September 2000
    0 references
    0 references
    356
    0 references
    9234
    0 references
    961-7
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit